Bay Colony Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $412K | Sell |
7,151
-134
| -2% | -$7.69K | 0.05% | 306 |
|
|
2026
Q1 | $442K | Sell |
7,285
-15,618
| -68% | -$910K | 0.05% | 288 |
|
|
2025
Q4 | $1.24M | Buy |
22,903
+16,702
| +269% | +$803K | 0.15% | 133 |
|
|
2025
Q3 | $280K | Sell |
6,201
-4,208
| -40% | -$197K | 0.03% | 409 |
|
|
2025
Q2 | $482K | Sell |
10,409
-23
| -0.2% | -$1.13K | 0.07% | 247 |
|
|
2025
Q1 | $626K | Buy |
10,432
+178
| +2% | +$10.4K | 0.1% | 201 |
|
|
2024
Q4 | $580K | Buy |
10,254
+865
| +9% | +$48.3K | 0.09% | 218 |
|
|
2024
Q3 | $486K | Buy |
9,389
+2,288
| +32% | +$107K | 0.07% | 240 |
|
|
2024
Q2 | $295K | Sell |
7,101
-11,998
| -63% | -$537K | 0.05% | 296 |
|
|
2024
Q1 | $1.04M | Sell |
19,099
-1,103
| -5% | -$56.2K | 0.18% | 123 |
|
|
2023
Q4 | $1.04M | Sell |
20,202
-11,576
| -36% | -$608K | 0.2% | 114 |
|
|
2023
Q3 | $1.84M | Buy |
31,778
+151
| +0.5% | +$9.25K | 0.44% | 52 |
|
|
2023
Q2 | $2.02M | Buy |
31,627
+402
| +1% | +$27K | 0.49% | 44 |
|
|
2023
Q1 | $2.13M | Sell |
31,225
-4,158
| -12% | -$293K | 0.56% | 40 |
|
|
2022
Q4 | $2.55M | Sell |
35,383
-442
| -1% | -$33.3K | 0.67% | 31 |
|
|
2022
Q3 | $2.55M | Sell |
35,825
-112
| -0.3% | -$8.13K | 0.76% | 25 |
|
|
2022
Q2 | $2.65M | Sell |
35,937
-3,231
| -8% | -$246K | 0.68% | 29 |
|
|
2022
Q1 | $2.86M | Buy |
39,168
+2,258
| +6% | +$152K | 0.68% | 29 |
|
|
2021
Q4 | $2.3M | Buy |
36,910
+2,017
| +6% | +$118K | 0.66% | 34 |
|
|
2021
Q3 | $2.06M | Buy |
34,893
+6,720
| +24% | +$443K | 0.68% | 36 |
|
|
2021
Q2 | $1.88M | Buy |
28,173
+501
| +2% | +$32.7K | 0.63% | 37 |
|
|
2021
Q1 | $1.75M | Buy |
27,672
+2,538
| +10% | +$158K | 0.67% | 34 |
|
|
2020
Q4 | $1.56M | Buy |
25,134
+564
| +2% | +$34.7K | 0.83% | 21 |
|
|
2020
Q3 | $1.48M | Buy |
24,570
+7,552
| +44% | +$455K | 0.92% | 20 |
|
|
2020
Q2 | $1M | Sell |
17,018
-716
| -4% | -$42.8K | 0.72% | 42 |
|
|
2020
Q1 | $989K | Buy |
17,734
+1,323
| +8% | +$80.9K | 0.9% | 28 |
|
|
2019
Q4 | $1.11M | Buy |
16,411
+4,401
| +37% | +$252K | 0.72% | 31 |
|
|
2019
Q3 | $609K | Buy |
12,010
+7,544
| +169% | +$355K | 0.41% | 82 |
|
|
2019
Q2 | $203K | Buy |
+4,466
| New | +$208K | 0.13% | 198 |
|
|
2019
Q1 | – | Sell |
-4,398
| Closed | -$229K | – | 217 |
|
|
2018
Q4 | $229K | Sell |
4,398
-1,963
| -31% | -$105K | 0.19% | 135 |
|
|
2018
Q3 | $395K | Buy |
6,361
+231
| +4% | +$13.7K | 0.3% | 102 |
|
|
2018
Q2 | $339K | Buy |
+6,130
| New | +$331K | 0.24% | 97 |
|
Other funds holding BMY
Bay Colony Advisors's BMY Position: Q2 2026 in Review
Bay Colony Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, selling an estimated $7.69K and leaving 7,151 shares worth $412K. The position accounts for 0.05% of the portfolio, ranked #306.
Bay Colony Advisors first reported a position in BMY in Q2 2018 and has held it in 32 quarters since. The position peaked at $2.86M in Q1 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bay Colony Advisors held 7,151 shares of Bristol-Myers Squibb worth $412K as of Q2 2026.
- Bay Colony Advisors sold 134 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.69K.
- Bristol-Myers Squibb made up 0.05% of Bay Colony Advisors's portfolio in Q2 2026, its #306 holding.
- Bay Colony Advisors first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 32 quarters since.
- Bay Colony Advisors's Bristol-Myers Squibb position peaked at $2.86M in Q1 2022.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.